4.5 Article

Galectin-1 expression in the serum and placenta of pregnant women with fetal growth restriction and its significance

期刊

BMC PREGNANCY AND CHILDBIRTH
卷 21, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12884-020-03477-8

关键词

Fetal growth restriction; Pregnant women; Galactose agglutination 1; Serum; The placenta

资金

  1. Zhejiang Province Public Welfare Technology Application Research Project in China [LGF19H040008]
  2. Taizhou Municipal Science and Technology Bureau in China [15yw01, 1701KY02]

向作者/读者索取更多资源

This study investigated the expression of Gal-1 in the serum and placenta of pregnant women with FGR. The results showed that Gal-1 levels were lower in the serum and placenta of FGR women compared to the control group. Gal-1 may play a role in the pathogenesis of FGR and could serve as a potential diagnostic marker for the disease.
BackgroundThis study aims to investigate galectin-1 (Gal-1) expression in the serum and placenta of pregnant women with fetal growth restriction (FGR) and its significance.MethodsThirty-one pregnant women with single-birth FGR but without comorbidities, eight pregnant women with FGR and preeclampsia (PE), and eight pregnant women with FGR and gestational diabetes mellitus (GDM) were enrolled as the study group, while 20 pregnant women with normal singleton pregnancy in the same period were enrolled as the control group. The serum Gal-1 level was detected using an enzyme-linked immunosorbent assay (ELISA), and Gal-1 expression in the placenta was detected by western blot.ResultsThe results revealed that, compared with the control group, the serum Gal-1 level decreased in the women with FGR without comorbidities, and the difference was statistically significant (P<0.001). Compared with the control group, the difference in serum Gal-1 expression in the FGR-PE group was not statistically significant (P=0.29). The peripheral serum Gal-1 level decreased in the FGR-GDM group compared with the control group, and the difference was statistically significant (P<0.001). The serum Gal-1 level was positively correlated with birth weight (r(2)=0.172, P<0.01). Compared with the control group, the Gal-1 expression level decreased in the placenta of the pregnant women with FGR without comorbidities (P<0.05).ConclusionsGal-1 exhibits low expression in the serum and placenta of pregnant women with FGR. In addition, Gal-1 may be involved in the pathogenesis of FGR and could represent a new diagnostic marker of the disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据